Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 29


Uniquely conformed peptide-containing beta 2-microglobulin-free heavy chains of HLA-B2705 on the cell surface.

Malik P, Klimovitsky P, Deng LW, Boyson JE, Strominger JL.

J Immunol. 2002 Oct 15;169(8):4379-87.


KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.

Faure M, Long EO.

J Immunol. 2002 Jun 15;168(12):6208-14.


Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.

Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P.

J Pathol. 2002 Mar;196(3):266-74.


The truncated cytoplasmic tail of HLA-G serves a quality-control function in post-ER compartments.

Park B, Lee S, Kim E, Chang S, Jin M, Ahn K.

Immunity. 2001 Aug;15(2):213-24.


HLA-G expression by tumors.

Davies B, Hiby S, Gardner L, Loke YW, King A.

Am J Reprod Immunol. 2001 Feb;45(2):103-7.


The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins.

Valés-Gómez M, Erskine RA, Deacon MP, Strominger JL, Reyburn HT.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1734-9. Epub 2001 Feb 6.


HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.

King A, Allan DS, Bowen M, Powis SJ, Joseph S, Verma S, Hiby SE, McMichael AJ, Loke YW, Braud VM.

Eur J Immunol. 2000 Jun;30(6):1623-31.


Cobalt-mediated dimerization of the human natural killer cell inhibitory receptor.

Fan QR, Long EO, Wiley DC.

J Biol Chem. 2000 Aug 4;275(31):23700-6.


Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.

Allen RL, O'Callaghan CA, McMichael AJ, Bowness P.

J Immunol. 1999 May 1;162(9):5045-8.


Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells.

Allan DS, Colonna M, Lanier LL, Churakova TD, Abrams JS, Ellis SA, McMichael AJ, Braud VM.

J Exp Med. 1999 Apr 5;189(7):1149-56.


A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.

Rajagopalan S, Long EO.

J Exp Med. 1999 Apr 5;189(7):1093-100. Erratum in: J Exp Med 2000 Jun 5;191(11):following 2027.


The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.

Navarro F, Llano M, Bellón T, Colonna M, Geraghty DE, López-Botet M.

Eur J Immunol. 1999 Jan;29(1):277-83.


Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors.

Valés-Gómez M, Reyburn HT, Erskine RA, Strominger J.

Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14326-31.


Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors.

Valés-Gómez M, Reyburn HT, Mandelboim M, Strominger JL.

Immunity. 1998 Sep;9(3):337-44. Erratum in: Immunity 1998 Dec;9(6):892.


p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily.

Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, Biassoni R.

Eur J Immunol. 1998 Jun;28(6):1980-90. Erratum in: Eur J Immunol 1998 Oct;28(10):3398.


Multiple receptors for HLA-G on human natural killer cells.

Mandelboim O, Pazmany L, Davis DM, Valés-Gómez M, Reyburn HT, Rybalov B, Strominger JL.

Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14666-70.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk